Please use this identifier to cite or link to this item:
|Title:||Transmission of community- And hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study||Authors:||Mo, Yin
Eyre, David W.
Lumley, Sheila F.
Walker, Timothy M.
Shaw, Robert H.
Donnelly, Christl A.
Cooper, Ben S.
|Issue Date:||12-Oct-2021||Publisher:||Public Library of Science||Citation:||Mo, Yin, Eyre, David W., Lumley, Sheila F., Walker, Timothy M., Shaw, Robert H., O’Donnell, Denise, Butcher, Lisa, Jeffery, Katie, Donnelly, Christl A., Cooper, Ben S. (2021-10-12). Transmission of community- And hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study. PLoS Medicine 18 (10) : e1003816. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pmed.1003816||Rights:||Attribution 4.0 International||Abstract:||Background AU Nosocomial: Pleaseconfirmthatallheadinglevelsarerepresentedcorrectly spread of Severe Acute Respiratory Syndrome:Coronavirus 2 (SARSAU -CoV-2): Pleasenot has been widely reported, but the transmission pathways among patients and healthcare workers (HCWs) are unclear. Identifying the risk factors and drivers for these nosocomial transmissions is critical for infection prevention and control interventions. The main aim of our study was to quantify the relative importance of different transmission pathways of SARS-CoV-2 in the hospital setting. Methods and findings This is an observational cohort study using data from 4 teaching hospitals in Oxfordshire, United Kingdom, from January to October 2020. Associations between infectious SARS-CoV-2 individuals and infection risk were quantified using logistic, generalised additive and linear mixed models. Cases were classified as community- or hospital-acquired using likely incubation periods of 3 to 7 days. OfAU 66,184: PerPLOSstyle patients who ; numeralsarenotallowedatthebeginningofase were hospitalised during the study period, 920 had a positive SARS-CoV-2 PCR test within the same period (1.4%). The mean age was 67.9 (±20.7) years, 49.2% were females, and 68.5% were from the white ethnic group. Out of these, 571 patients had their first positive PCR tests while hospitalised (62.1%), and 97 of these occurred at least 7 days after admission (10.5%). Among the 5,596 HCWs, 615 (11.0%) tested positive during the study period using PCR or serological tests. The mean age was 39.5 (±11.1) years, 78.9% were females, and 49.8% were nurses. For susceptible patients, 1 day in the same ward with another patient with hospital-acquired SARS-CoV-2 was associated with an additional 7.5 infections per 1,000 susceptible patients (95% credible interval (CrI) 5.5 to 9.5/1,000 susceptible patients/day) per day. Exposure to an infectious patient with community-acquired Coronavirus Disease 2019 (COVIDAU -19):or Pleas to an infectious HCW was associated with substantially lower infection risks (2.0/1,000 susceptible patients/day, 95% CrI 1.6 to 2.2). As for HCW infections, exposure to an infectious patient with hospital-acquired SARS-CoV-2 or to an infectious HCW were both associated with an additional 0.8 infection per 1,000 susceptible HCWs per day (95% CrI 0.3 to 1.6 and 0.6 to 1.0, respectively). Exposure to an infectious patient with community-acquired SARS-CoV-2 was associated with less than half this risk (0.2/1,000 susceptible HCWs/day, 95% CrI 0.2 to 0.2). These assumptions were tested in sensitivity analysis, which showed broadly similar results. The main limitations were that the symptom onset dates and HCW absence days were not available. Conclusions In this study, we observed that exposure to patients with hospital-acquired SARS-CoV-2 is associated with a substantial infection risk to both HCWs and other hospitalised patients. Infection control measures to limit nosocomial transmission must be optimised to protect both staff and patients from SARS-CoV-2 infection. Copyright: © 2021 Mo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.||Source Title:||PLoS Medicine||URI:||https://scholarbank.nus.edu.sg/handle/10635/232390||ISSN:||1549-1277||DOI:||10.1371/journal.pmed.1003816||Rights:||Attribution 4.0 International|
|Appears in Collections:||Elements|
Show full item record
Files in This Item:
|10_1371_journal_pmed_1003816.pdf||1.38 MB||Adobe PDF|
checked on Nov 29, 2022
checked on Dec 1, 2022
This item is licensed under a Creative Commons License